A Canadian, retrospective, multicenter experience with selexipag for a heterogeneous group of pediatric pulmonary hypertension patients

• Main Authors: David Youssef (Author), Susan Richards (Author), Sabine Lague (Author), Catherine Sheppard (Author), Jenna Smith (Author), Erika Vorhies (Author), Martin Hosking (Author), Matthew Pietrosanu (Author), Angela Bates (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

IntroductionSelexipag, an oral nonprostanoid prostaglandin receptor agonist, has led to reduced morbidity and mortality in adults with pulmonary arterial hypertension (PAH). While the adult literature has been extrapolated to suggest selexipag as an oral treatment for severe pediatric pulmonary hype...